More than nine in 10 patients treated with Roche’s next-generation Alzheimer’s disease antibody trontinemab tested negative for amyloid plaques in a mid-stage study, marking a return to the ...

The White House released the results of President Donald Trump's recent advanced imaging tests on Monday, describing them as ...

Scientists have discovered that the brain may have a built-in way to fight Alzheimer’s.

Aug. 13 -- TUESDAY, Aug. 12 (HealthDay News) -- PET scans may provide doctors with a non-invasive method of detecting Alzheimer's disease-related brain plaques, Finnish researchers say. Currently, the ...

In December 2025, U.S. President Donald Trump announced a Magnetic Resonance Imaging scan on his brain "found nothing." Trump did have an MRI scan in October 2025, but it was reportedly on his ...

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs).

On its own, LATE dementia is less severe than Alzheimer’s, but in combination, it makes Alzheimer’s symptoms worse, ...

A small study indicates regular blood tests could be a useful addition to brain scans that track the progression of Alzheimer ...

This change in brain activity was found to be partly independent of tau protein buildup and a person’s education level (used ...

A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network in the short term.

GE HealthCare aims to further build out its portfolio of programs focused on brain scans with a deal to acquire the MRI artificial intelligence developer icometrix following years of collaborating.